Drug Approval | June 07, 2024
Indoco Remedies receives tentative ANDA approval for Canagliflozin, Metformin Hydrochloride Tablets
Canagliflozin and Metformin Hydrochloride Tablets are used to treat type 2 diabetes mellitus
Canagliflozin and Metformin Hydrochloride Tablets are used to treat type 2 diabetes mellitus
Dual immunotherapy combination of Opdivo plus Yervoy demonstrated improved survival benefit compared to lenvatinib or sorafenib in this patient population
Sacubitril and Valsartan Tablets are indicated to reduce the risk of cardiovascular death
Theophylline is used to treat asthma and chronic obstructive pulmonary disease
Dexamethasone Tablets USP, 1 mg had annual sales of US$ 1.8 mn in the United States (IQVIA MAT March 24)
Sevelamer Carbonate Tablets approval consolidates the company's position in the Sevelamer segment
New advanced technology-enabled offering aims to streamline synthetic route identification for novel active pharmaceutical ingredients (APIs)
Glenmark’s Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg (OTC), will be distributed in the U.S. by Glenmark Therapeutics, USA
The company will closely work with the USFDA to address and respond to the observations in an expeditious manner
Desidustat, administered orally is a novel, oral Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (HIF-PHI) for treating anaemia in Chronic Kidney Disease (CKD) patients
Subscribe To Our Newsletter & Stay Updated
